Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EMEA Should Adopt More FDA Methods To Speed Drug Approval - CPMP Chair

Executive Summary

The European Medicines Evaluation Agency should consider the adoption of more FDA-style mechanisms to speed approval of important new drugs, Commission for Proprietary Medicinal Products Chairman Jean-Michel Alexandre, PhD, indicated.

You may also be interested in...



Swedish Regulatory Agency Deputy Director Lonngren Will Head EMEA

Swedish Medical Products Agency Deputy Director Thomas Lonngren will try to maintain the performance and acceptance levels of the EMEA following the departure of the agency's first director, Fernand Sauer.

Swedish Regulatory Agency Deputy Director Lonngren Will Head EMEA

Swedish Medical Products Agency Deputy Director Thomas Lonngren will try to maintain the performance and acceptance levels of the EMEA following the departure of the agency's first director, Fernand Sauer.

EU Orphan Designations Expected By Third Quarter; 24 Applications Received

EMEA's Committee for Orphan Medicinal Products expects to deliver its first orphan drug designations by the third quarter of this year, the committee said.

UsernamePublicRestriction

Register

LL1135544

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel